A patient with lung cancer and COPD presents with increased shortness of breath and diminished breath sounds on the right side. A chest X-ray reveals a right-sided pleural effusion. Which nursing intervention is most appropriate to address the patient's immediate respiratory needs?

B) Prepare the patient for thoracentesis as ordered

A) Increase the oxygen flow rate to 4L/min via nasal cannula

B) Prepare the patient for thoracentesis as ordered

C) Encourage the patient to perform incentive spirometry every hour

D) Administer a bronchodilator nebulizer treatment

A patient with a history of lung cancer and COPD is experiencing increased shortness of breath, requiring supplemental oxygen. A chest X-ray reveals a new right-sided pleural effusion. Which nursing intervention is most appropriate to prioritize in the care of this patient?

D) Prepare the patient for thoracentesis to relieve pleural effusion

A) Administer a higher flow of oxygen to maintain SpO2 above 95%

B) Position the patient in a high Fowler's position to facilitate lung expansion

C) Encourage the patient to perform incentive spirometry to prevent atelectasis

D) Prepare the patient for thoracentesis to relieve pleural effusion

A patient with metastatic lung cancer post-thoracentesis shows stable oxygen saturation but develops a productive cough with hemoptysis and mild leukocytosis. Given these findings, which nursing intervention is most appropriate to address his current symptoms and overall condition?

C) Initiate a referral to the palliative care team to discuss symptom management and quality of life.

A) Administer prescribed antibiotics to prevent secondary bacterial infection.

B) Educate the patient and family about the importance of hydration to help manage fatigue and renal function.

C) Initiate a referral to the palliative care team to discuss symptom management and quality of life.

D) Increase oxygen flow rate to address the patient's decreased respiratory function.

A patient with metastatic lung cancer has undergone thoracentesis and is now showing new symptoms, including a productive cough with hemoptysis, increased fatigue, and a slight decline in renal function. Considering the current clinical findings, which nursing intervention is most appropriate to prioritize for this patient?

C) Monitor and report changes in renal function and prepare for possible nephrology consultation.

A) Increase the patient's oxygen flow rate to ensure adequate oxygenation.

B) Initiate a referral to the dietitian to address potential nutritional deficits due to fatigue.

C) Monitor and report changes in renal function and prepare for possible nephrology consultation.

D) Educate the patient and family about the side effects of the proposed chemotherapy regimen.

A patient with advanced lung cancer is experiencing increased respiratory distress and a decline in renal function. As part of the nursing care plan, which intervention is the priority to address the patient's current symptoms and maintain quality of life?

D) Administer prescribed analgesics and anxiolytics to manage pain and dyspnea.

A) Increase the patient's oxygen delivery to 6L/min to improve oxygen saturation.

B) Collaborate with the healthcare team to initiate diuretics to manage the pleural effusion.

C) Discuss with the patient and family about goals of care and advance directives.

D) Administer prescribed analgesics and anxiolytics to manage pain and dyspnea.

A patient with metastatic lung cancer is experiencing increased respiratory distress, a productive cough with hemoptysis, and diminished renal function. The multidisciplinary team is considering changes to the patient's chemotherapy regimen. What is the priority nursing intervention to address the patient's current symptoms and support the patient's care plan?

C) Coordinate with the healthcare team to optimize pain and dyspnea management as part of palliative care.

A) Administer bronchodilators to improve airway clearance and oxygenation.

B) Discuss with the patient and family about transitioning to hospice care given the advanced disease stage.

C) Coordinate with the healthcare team to optimize pain and dyspnea management as part of palliative care.

D) Focus on aggressive hydration to improve renal function and support chemotherapy administration.

A patient with metastatic lung cancer presents with increased respiratory distress, a reaccumulated pleural effusion, and declining renal function. In planning nursing interventions, which action is the priority to address the patient's immediate needs?

C) Implement interventions to optimize oxygenation and manage dyspnea.

A) Administer prescribed diuretics to manage the pleural effusion.

B) Collaborate with the healthcare team to adjust the chemotherapy protocol considering renal function.

C) Implement interventions to optimize oxygenation and manage dyspnea.

D) Initiate discussions about advanced care planning with the patient and family.

A patient with advanced lung cancer presents with increased respiratory distress, diminished breath sounds, bilateral crackles, and a small right-sided pleural effusion. The patient's renal function is declining with a creatinine level of 2.0 mg/dL. Which nursing intervention should the nurse prioritize to address the patient's respiratory symptoms while considering his renal status?

C) Position the patient in a semi-Fowler's position

A) Increase the patient's oxygen flow rate to 5L/min

B) Administer diuretics to reduce pleural effusion

C) Position the patient in a semi-Fowler's position

D) Initiate nebulized bronchodilator therapy

A patient with worsening respiratory distress and laboratory findings of respiratory acidosis is under your care. Which intervention should the nurse prioritize in collaboration with the healthcare team to address the patient's current respiratory status?

C) Initiate non-invasive ventilation using a BiPAP machine.

A) Increase the oxygen flow rate to 6L/min via nasal cannula.

B) Prepare the patient for possible intubation and mechanical ventilation.

C) Initiate non-invasive ventilation using a BiPAP machine.

D) Encourage the patient to perform incentive spirometry every hour.

A patient with worsening respiratory distress, increased respiratory rate, and altered level of consciousness is being treated for possible respiratory infection and acute respiratory failure. Given the patient's ABG results indicating respiratory acidosis, which intervention should the nurse anticipate as a priority to improve gas exchange?

B) Prepare the patient for non-invasive ventilation, such as CPAP or BiPAP

A) Administer high-flow oxygen therapy at 8 L/min via nasal cannula

B) Prepare the patient for non-invasive ventilation, such as CPAP or BiPAP

C) Increase the frequency of nebulizer treatments with bronchodilators

D) Position the patient in a high-Fowler's position to facilitate lung expansion

Akciğer CA - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutations in lung cells lead to uncontrolled cell proliferation. Key mutations often involve oncogenes like KRAS and tumor suppressor genes like TP53, disrupting normal cell cycle regulation and promoting tumor growth.

• Secondary mechanism: Chronic exposure to carcinogens, such as tobacco smoke, causes DNA damage and inflammation. This persistent damage triggers further genetic alterations, enhancing malignant transformation and tumor progression.

• Key complication: Tumor invasion into surrounding tissues and metastasis to distant organs, particularly the brain, bones, and liver, can lead to significant clinical complications like respiratory distress, neurological deficits, and bone pain.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Chronic obstructive pulmonary disease (COPD), 15 pack-year smoking history, hypertension

• Current medications: Albuterol inhaler, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Hemoptysis, unexplained weight loss, fatigue, chest pain

• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 89% on room air

Section 1

As the healthcare team continues to monitor the patient, they notice a significant change in his respiratory status. Over the course of a few days, his shortness of breath becomes more pronounced, with the patient now requiring supplemental oxygen to maintain adequate saturation levels. Despite being on continuous low-flow oxygen at 2L/min via nasal cannula, his oxygen saturation struggles to stay above 92%. His respiratory rate has increased to 28 breaths per minute, indicating increased work of breathing. Auscultation of the lungs reveals diminished breath sounds on the right side, and the presence of wheezes and crackles, suggesting possible atelectasis or pleural effusion.

Given these findings, a chest X-ray is ordered, revealing a new right-sided pleural effusion and a possible mass effect contributing to the patient’s respiratory compromise. This effusion is likely secondary to the progression of his lung cancer, causing compression of the lung tissue and further impairing gas exchange. The decision is made to perform a thoracentesis to relieve the pressure and obtain pleural fluid for cytological analysis, which could provide further insight into the cancer's progression or reveal a secondary infection.

These developments prompt the healthcare team to reassess the patient's treatment plan. The immediate focus shifts to stabilizing his respiratory status while considering more aggressive oncological interventions. The presence of the pleural effusion and potential tumor growth necessitates discussions around the possibility of chemotherapy or radiation therapy to manage the tumor burden effectively. The team must also weigh the risks and benefits of these interventions, considering the patient's existing COPD and overall functional status. This evolving scenario underlines the importance of a multidisciplinary approach, involving oncologists, pulmonologists, and palliative care specialists to optimize patient outcomes.

Section 2

Following the thoracentesis, the patient's respiratory status initially shows signs of improvement, with a slight decrease in respiratory rate to 24 breaths per minute and oxygen saturation stabilizing at 94% on 2L/min of oxygen. The pleural fluid analysis, however, reveals malignant cells consistent with metastatic lung cancer, confirming the progression of the disease. Additionally, the cytological examination indicates no evidence of infection, ruling out any secondary bacterial involvement.

Despite the temporary relief from the thoracentesis, the patient begins to exhibit new symptoms. He develops a persistent cough, now productive with scant hemoptysis, and his overall fatigue increases. A repeat complete blood count shows a mild leukocytosis at 12,000/mm³, which raises concerns for possible paraneoplastic syndrome or another underlying inflammatory process. His renal function, previously stable, shows a slight decline with a creatinine level rising to 1.8 mg/dL, warranting careful monitoring given his recent exposure to contrast for imaging studies.

The healthcare team is now faced with the challenge of adapting the treatment plan in light of these findings. The oncologist suggests initiating a chemotherapy regimen tailored to the patient's specific cancer subtype, while the palliative care team emphasizes maintaining quality of life. Discussions about the patient's goals of care become increasingly important as the team considers the potential side effects of aggressive cancer treatment against the backdrop of his worsening symptoms and comorbidities. This scenario highlights the complexity of balancing intervention efficacy with quality of life, necessitating ongoing communication among all team members and the patient’s family.

Section 3

As the healthcare team continues to monitor the patient, new complications emerge that further complicate his clinical picture. Over the next few days, the patient experiences an increase in his respiratory distress, with his respiratory rate climbing back to 28 breaths per minute, and his oxygen saturation dropping to 90% on 3L/min of oxygen. Auscultation reveals diminished breath sounds on the affected side, accompanied by increased crackles bilaterally, suggesting worsening pulmonary involvement. The productive cough with hemoptysis persists, raising concerns about possible tumor hemorrhage or further metastatic spread within the lungs.

In response to these developments, a high-resolution CT scan of the chest is ordered, which reveals not only an increase in the size of the primary lung mass but also new nodular infiltrates in both lungs, suggestive of metastatic progression. Additionally, a small right-sided pleural effusion has reaccumulated, contributing to the patient's breathing difficulties. Given the new findings, the oncologist proposes initiating a different chemotherapy protocol aimed at targeting the more aggressive nature of the disease. However, the patient's declining renal function, now with a creatinine level of 2.0 mg/dL, poses a significant risk for nephrotoxicity, necessitating a careful balance between effective cancer treatment and minimizing further renal compromise.

These changes prompt a multidisciplinary meeting to reassess the management plan. The palliative care team reiterates the importance of addressing the patient's symptom burden, emphasizing the need for effective pain and dyspnea management. They also discuss with the patient and his family the importance of advanced care planning, encouraging them to consider the patient's values and preferences regarding end-of-life care. This scenario requires the healthcare team to engage in complex clinical reasoning, weighing the benefits and risks of aggressive treatments against the patient's quality of life, and maintaining an open dialogue with the patient and family to ensure that care aligns with the patient's goals.

Section 4

As the healthcare team continues to monitor the patient, new complications emerge, further complicating his clinical picture. Over the next few days, the patient experiences an increase in his respiratory distress, with his respiratory rate climbing back to 28 breaths per minute, and his oxygen saturation dropping to 90% on 3L/min of oxygen. Auscultation reveals diminished breath sounds on the affected side, accompanied by increased crackles bilaterally, suggesting worsening pulmonary involvement. The productive cough with hemoptysis persists, raising concerns about possible tumor hemorrhage or further metastatic spread within the lungs.

Section 5

Change in Patient Status:

Over the following days, the patient's clinical status continues to deteriorate despite the adjustments in his treatment plan. His respiratory distress worsens, and his respiratory rate increases to 32 breaths per minute, while his oxygen saturation drops further to 86% on 4L/min of oxygen. The patient's level of consciousness begins to fluctuate; he becomes intermittently confused and lethargic, indicating possible hypoxemia and hypercapnia. Vital signs reveal a low-grade fever of 38.2°C, a heart rate of 110 beats per minute, and blood pressure at 98/62 mmHg. These changes raise concerns about the development of a superimposed infection or acute respiratory failure.

In light of these developments, the healthcare team initiates further investigations to explore potential causes for the patient's declining status. Blood cultures are drawn, and broad-spectrum antibiotics are started empirically to address the possibility of a respiratory infection. Repeat arterial blood gases (ABG) show a pH of 7.30, PaCO2 of 58 mmHg, and PaO2 of 55 mmHg, confirming a respiratory acidosis likely due to alveolar hypoventilation and impaired gas exchange. These findings necessitate an urgent reevaluation of the patient's respiratory support, with consideration for escalation to non-invasive ventilation.

The worsening renal function is also addressed, with the nephrology team closely monitoring fluid balance and adjusting medications to mitigate further nephrotoxicity. The patient's family is updated on the current situation, and discussions regarding the goals of care are revisited with an emphasis on understanding the patient's wishes in the context of his rapidly evolving condition. The team continues to weigh the options between aggressive treatment and comfort-focused care, striving to align their interventions with the patient's values and preferences. This critical juncture in the patient's journey underscores the importance of integrated care coordination and clear communication among all parties involved.